|
Wed, 06/12/2024 - 06:16 |
Sobi to present new data across its haematology portfolio at the 2024 EHA congress |
Swedish Orphan ... |
|
Sun, 05/19/2024 - 18:47 |
Clinicians Report Success with First Test of Drug in a Patient with Life-Threatening Blood Clotting Disorder |
Massachusetts G... |
|
Fri, 05/13/2022 - 06:33 |
Sobi to present new data in both PNH and ITP at the 2022 EHA congress |
Swedish Orphan ... |
|
Thu, 04/14/2022 - 15:06 |
Positive Phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine |
Sanofi |
|
Tue, 09/28/2021 - 04:01 |
Grifols begins commercializing TAVLESSE in France, Italy and Spain to treat chronic immune thrombocytopenia |
Grifols |
|
Wed, 08/25/2021 - 06:49 |
CTI BioPharma and DRI Healthcare Trust Announce up to $135 Million Debt and Royalty Transaction |
CTI BioPharma |
|
Tue, 06/01/2021 - 08:43 |
CTI BioPharma Announces Acceptance of NDA Granted with Priority Review of Pacritinib for Treatment of Patients with Myelofibrosis |
CTI BioPharma |
|
Thu, 04/22/2021 - 12:28 |
Study outlines mechanism behind rare blood clots linked to COVID-19 vaccine |
University of B... |
|
Wed, 04/21/2021 - 15:17 |
Fresenius Kabi Introduces Low Concentration Heparin Sodium in Sodium Chloride Injection in Ready-to-Use Freeflex Bags |
Fresenius Kabi |
|
Wed, 01/20/2021 - 05:08 |
Doptelet (avatrombopag) approved in the EU for treatment of ITP |
Swedish Orphan ... |
|
Thu, 12/10/2020 - 22:34 |
Doptelet (avatrombopag) receives positive opinion from CHMP for treatment of ITP |
Swedish Orphan ... |
|
Mon, 11/23/2020 - 09:47 |
Rigel and Medison Announce Health Canada Approval of TAVALISSE, an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia |
Rigel Pharmaceu... |
|
Wed, 11/18/2020 - 08:44 |
Rilzabrutinib granted FDA Fast Track Designation for treatment of immune thrombocytopenia |
Sanofi |
|
Wed, 11/04/2020 - 06:53 |
Sobi launch Doptelet (avatrombopag) in Europe |
Swedish Orphan ... |
|
Tue, 10/13/2020 - 10:34 |
CTI BioPharma Initiates Rolling Submission of New Drug Application (NDA) for Pacritinib in Myelofibrosis Patients with Severe Thrombocytopenia |
CTI BioPharma |
|
Fri, 10/09/2020 - 09:31 |
Sobi announces topline phase 3 data of avatrombopag for the treatment of Chemotherapy-Induced Thrombocytopenia |
Swedish Orphan ... |
|
Wed, 08/12/2020 - 00:21 |
National Blood Foundation Announces 2020 Early-Career Grant Recipients |
AABB |
|
Mon, 07/27/2020 - 14:51 |
Rigel Announces Post-hoc Data Analysis of TAVALISSE in Adult Patients with Immune Thrombocytopenia Published in the British Journal of Haematology |
Rigel Pharmaceu... |
|
Wed, 07/15/2020 - 11:36 |
The ISTH Publishes First Clinical Practice Guidelines for Thrombotic Thrombocytopenic Purpura |
ISTH |
|
Thu, 03/19/2020 - 18:42 |
DOPTELET (avatrombopag) Now Available at Biologics by McKesson |
McKesson |
|
Wed, 02/12/2020 - 12:15 |
Meet Uplifting Athletes 2019 Rare Disease Champion Team member Sam Heckel from Syracuse University |
Uplifting Athletes |
|
Sat, 12/21/2019 - 05:57 |
FDA grants avatrombopag Orphan Drug Designation for the treatment of Chemotherapy-Induced Thrombocytopenia |
Lions Clubs |
|
Sat, 12/21/2019 - 05:20 |
Fda grants avatrombopag orphan drug designation treatment chemotherapy induced |
Lions Clubs |
|
Tue, 12/17/2019 - 16:09 |
Rigel Announces Chief Commercial Officer Transition |
Rigel Pharmaceu... |
|
Thu, 12/05/2019 - 15:33 |
Data to be highlighted at the American Society of Hematology 2019 Annual Meeting |
Swedish Orphan ... |
